Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Spectinomycin
Drug ID BADD_D02063
Description An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of gonorrhea.
Indications and Usage For use in the treatment of acute gonorrheal urethritis and proctitis in the male and acute gonorrheal cervicitis and proctitis in the female when due to susceptible strains of Neisseria gonorrhoeae.
Marketing Status approved; investigational; vet_approved
ATC Code J01XX04
DrugBank ID DB00919
KEGG ID D08526
MeSH ID D000198
PubChem ID 15541
TTD Drug ID D02PCR
NDC Product Code 0009-5038
UNII 93AKI1U6QF
Synonyms Spectinomycin | Actinospectacin | Prospec | Ferkel Spectam | Spectam, Ferkel | Kempi | Spectinomycin Dihydrochloride, Pentahydrate | Spectam | Spectinomycin Dihydrochloride, Anhydrous | Trobicin | Salmosan-T | Salmosan T | Stanilo | Spectinomycin Hydrochloride | Adspec
Chemical Information
Molecular Formula C14H24N2O7
CAS Registry Number 1695-77-8
SMILES CC1CC(=O)C2(C(O1)OC3C(C(C(C(C3O2)NC)O)NC)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock10.01.07.002; 24.06.02.004---
Anaphylactoid reaction10.01.07.003; 24.06.03.007---
Body temperature increased13.15.01.001---
Chills08.01.09.001; 15.05.03.016--
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Hypersensitivity10.01.03.003--
Insomnia17.15.03.002; 19.02.01.002--
Nausea07.01.07.001--
Nephropathy toxic12.03.01.010; 20.05.03.002---
Tenderness08.01.08.005---
Urticaria10.01.06.001; 23.04.02.001--
Urine output13.13.03.003---
The 1th Page    1    Total 1 Pages